Jung E M, Wiggermann P, Stroszczynski C, Reiser M F, Clevert D-A
Institut für Röntgendiagnostik, Universitätsklinikum Regensburg (UKR), Franz-Josef-Strauss-Allee 11, Regensburg, Germany.
Radiologe. 2012 Aug;52(8):706-16. doi: 10.1007/s00117-012-2307-2.
The current improvements in modern high resolution ultrasound technology, like Tissue Harmonic Imaging (THI), Speckle Reduction Imaging (SRI), partial color coding of B-mode (Color Coded Imaging), and also the advent of ultrasound based elastography as well as contrast-enhanced ultrasound (CEUS) offer fundamentally new ways to characterize diffuse alterations of the liver parenchyma. Besides metabolic disease, disorders of liver fat distribution, infectious and malignant diseases can cause diffuse alterations of the liver parenchyma. In case of liver fibrosis, only a combination of different ultrasound techniques including CEUS, allows the differentiation between benign dysplastic and malignant lesions. Ultrasound elastography allows assessing the extent of the fibrosis. This article focuses on the different ultrasound based diagnostic possibilities in case of diffuse liver disease.
现代高分辨率超声技术的当前改进,如组织谐波成像(THI)、斑点减少成像(SRI)、B 模式的部分彩色编码(彩色编码成像),以及基于超声的弹性成像和对比增强超声(CEUS)的出现,为表征肝实质的弥漫性改变提供了全新的方法。除了代谢性疾病外,肝脏脂肪分布紊乱、感染性疾病和恶性疾病均可导致肝实质的弥漫性改变。在肝纤维化的情况下,只有包括 CEUS 在内的不同超声技术联合使用,才能区分良性发育异常和恶性病变。超声弹性成像可评估纤维化程度。本文重点介绍弥漫性肝病情况下基于超声的不同诊断可能性。